6 employees
ChromaCure discover and develop first-in-class small molecule therapeutics for unmet needs in oncology.
2018
$20M
from 5 investors over 5 rounds
ChromaCure raised $20M on May 29, 2018
Investors: SRIW, Theodorus Investment Funds, -, NEWTON BIOCAPITAL and -